Deadly Designer Drugs Smuggled on Paper Kill Six in Chicago Jail
Deadly Designer Drugs Smuggled on Paper Kill Six in Chicago Jail
Deadly Designer Drugs Smuggled on Paper Kill Six in Chicago Jail
A deadly wave of designer drugs has swept through a Chicago jail, leaving at least six inmates dead. The substances, smuggled in on ordinary paper, have baffled investigators and evaded prison security measures for over a year.
The first signs of trouble appeared when inmates began overdosing without any needles or drug paraphernalia in sight. Guards later discovered burned paper scraps near one victim, testing positive for toxic synthetic drugs. These substances, sprayed onto sheets of paper, book pages, and even photographs, were being ingested by prisoners seeking a temporary high.
Smugglers exploited everyday items to bypass security. Legal correspondence, Amazon packages, and books soaked in drugs all made their way into the facility. Despite heightened surveillance and searches, the flow of these substances continued unchecked. The problem extends beyond detection. The number of new synthetic drugs has tripled since 2013, with over 1,440 variants now identified. Their rapid evolution outpaces law enforcement's ability to track them. Justin Wilks, the lead investigator, spent more than a year probing the deaths but could not pinpoint the supplier. Inmates, desperate for escape, ingest the drug-laced paper for a fleeting high. Yet the consequences have been fatal, with multiple deaths reported and no clear solution in sight.
The crisis highlights the challenges of combating synthetic drugs in prisons. With smugglers adapting faster than authorities can respond, the death toll continues to rise. Investigators remain unable to trace the source, leaving the jail—and potentially others—vulnerable to further losses.
Untreated gum disease may double Alzheimer's risk over time
Your oral health might hold the key to brain protection. Scientists reveal how neglected gums could silently raise dementia risks decades later.
Sepsis kills nearly 1 in 5 hospitalized U.S. children, study reveals
One in seventy-five hospitalized kids develops sepsis—yet despite better tools, death rates haven't budged. Why is this silent killer still winning?
Groundbreaking trial tests twice-yearly injection for stubborn high blood pressure
Could a simple injection every six months transform hypertension care? Roche's $300M-backed trial seeks answers for patients who struggle with current treatments.
Malaysia's medicine supply stays stable amid West Asia tensions in 2026
How is Malaysia safeguarding its drug supply during geopolitical unrest? A task force, stockpiles, and real-time tracking keep shortages at bay.